613 related articles for article (PubMed ID: 24947525)
21. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice.
Ni M; Wang Y; Zhang M; Zhang PF; Ding SF; Liu CX; Liu XL; Zhao YX; Zhang Y
Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1598-606. PubMed ID: 19286965
[TBL] [Abstract][Full Text] [Related]
22. Comparison of two murine models of thrombosis induced by atherosclerotic plaque injury.
Hechler B; Gachet C
Thromb Haemost; 2011 May; 105 Suppl 1():S3-12. PubMed ID: 21479341
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis.
Welten SMJ; de Jong RCM; Wezel A; de Vries MR; Boonstra MC; Parma L; Jukema JW; van der Sluis TC; Arens R; Bot I; Agrawal S; Quax PHA; Nossent AY
Atherosclerosis; 2017 Jun; 261():26-36. PubMed ID: 28445809
[TBL] [Abstract][Full Text] [Related]
24. Silencing of Anticoagulant Protein C Evokes Low-Incident but Spontaneous Atherothrombosis in Apolipoprotein E-Deficient Mice-Brief Report.
Ouweneel AB; Heestermans M; Verwilligen RAF; Gijbels MJJ; Reitsma PH; Van Eck M; van Vlijmen BJM
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):782-785. PubMed ID: 28302625
[TBL] [Abstract][Full Text] [Related]
25. Intravital imaging of thrombus formation in small and large mouse arteries: experimentally induced vascular damage and plaque rupture in vivo.
Kuijpers MJ; Heemskerk JW
Methods Mol Biol; 2012; 788():3-19. PubMed ID: 22130696
[TBL] [Abstract][Full Text] [Related]
26. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice.
Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1831-4. PubMed ID: 10894825
[TBL] [Abstract][Full Text] [Related]
27. Intrinsic pathway of coagulation and arterial thrombosis.
Gailani D; Renné T
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2507-13. PubMed ID: 17916770
[TBL] [Abstract][Full Text] [Related]
28. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
Theelen TL; Lappalainen JP; Sluimer JC; Gurzeler E; Cleutjens JP; Gijbels MJ; Biessen EA; Daemen MJ; Alitalo K; Ylä-Herttuala S
Atherosclerosis; 2015 Aug; 241(2):297-304. PubMed ID: 26062989
[TBL] [Abstract][Full Text] [Related]
29. Spontaneous atherothrombosis and medial degradation in Apoe-/-, Npc1-/- mice.
Welch CL; Sun Y; Arey BJ; Lemaitre V; Sharma N; Ishibashi M; Sayers S; Li R; Gorelik A; Pleskac N; Collins-Fletcher K; Yasuda Y; Bromme D; D'Armiento JM; Ogletree ML; Tall AR
Circulation; 2007 Nov; 116(21):2444-52. PubMed ID: 17984379
[TBL] [Abstract][Full Text] [Related]
30. CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages.
Li J; Zhang P; Li T; Liu Y; Zhu Q; Chen T; Liu T; Huang C; Zhang J; Zhang Y; Guo Y
Biochem Biophys Res Commun; 2015 Mar; 458(4):890-5. PubMed ID: 25701788
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory immune skewing is atheroprotective: Apoe−/−FcγRIIb−/− mice develop fibrous carotid plaques.
Harmon EY; Fronhofer V; Keller RS; Feustel PJ; Zhu X; Xu H; Avram D; Jones DM; Nagarajan S; Lennartz MR
J Am Heart Assoc; 2014 Dec; 3(6):e001232. PubMed ID: 25516435
[TBL] [Abstract][Full Text] [Related]
32. Apolipoprotein E-deficient rats develop atherosclerotic plaques in partially ligated carotid arteries.
Wei S; Zhang Y; Su L; He K; Wang Q; Zhang Y; Yang D; Yang Y; Ma S
Atherosclerosis; 2015 Dec; 243(2):589-92. PubMed ID: 26545012
[TBL] [Abstract][Full Text] [Related]
33. Circulating and platelet-derived microparticles in human blood enhance thrombosis on atherosclerotic plaques.
Suades R; Padró T; Vilahur G; Badimon L
Thromb Haemost; 2012 Dec; 108(6):1208-19. PubMed ID: 23138460
[TBL] [Abstract][Full Text] [Related]
34. Impact of glycoprotein VI and platelet adhesion on atherosclerosis--a possible role of fibronectin.
Bültmann A; Li Z; Wagner S; Peluso M; Schönberger T; Weis C; Konrad I; Stellos K; Massberg S; Nieswandt B; Gawaz M; Ungerer M; Münch G
J Mol Cell Cardiol; 2010 Sep; 49(3):532-42. PubMed ID: 20430036
[TBL] [Abstract][Full Text] [Related]
35. Plaque-associated vasa vasorum in aged apolipoprotein E-deficient mice exhibit proatherogenic functional features in vivo.
Rademakers T; Douma K; Hackeng TM; Post MJ; Sluimer JC; Daemen MJ; Biessen EA; Heeneman S; van Zandvoort MA
Arterioscler Thromb Vasc Biol; 2013 Feb; 33(2):249-56. PubMed ID: 23241413
[TBL] [Abstract][Full Text] [Related]
36. Thrombosis formation on atherosclerotic lesions and plaque rupture.
Badimon L; Vilahur G
J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
[TBL] [Abstract][Full Text] [Related]
37. The role of PGE(2) in human atherosclerotic plaque on platelet EP(3) and EP(4) receptor activation and platelet function in whole blood.
Schober LJ; Khandoga AL; Dwivedi S; Penz SM; Maruyama T; Brandl R; Siess W
J Thromb Thrombolysis; 2011 Aug; 32(2):158-66. PubMed ID: 21424266
[TBL] [Abstract][Full Text] [Related]
38. Limited Macrophage Positional Dynamics in Progressing or Regressing Murine Atherosclerotic Plaques-Brief Report.
Williams JW; Martel C; Potteaux S; Esaulova E; Ingersoll MA; Elvington A; Saunders BT; Huang LH; Habenicht AJ; Zinselmeyer BH; Randolph GJ
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1702-1710. PubMed ID: 29903736
[TBL] [Abstract][Full Text] [Related]
39. Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice.
Wu DJ; Xu JZ; Wu YJ; Jean-Charles L; Xiao B; Gao PJ; Zhu DL
Atherosclerosis; 2009 Nov; 207(1):68-73. PubMed ID: 19473657
[TBL] [Abstract][Full Text] [Related]
40. Transglutaminase 2 deficiency decreases plaque fibrosis and increases plaque inflammation in apolipoprotein-E-deficient mice.
Van Herck JL; Schrijvers DM; De Meyer GR; Martinet W; Van Hove CE; Bult H; Vrints CJ; Herman AG
J Vasc Res; 2010; 47(3):231-40. PubMed ID: 19893320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
